Training biostatisticians in Nigeria for HIV research

Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)

['FUNDING_OTHER'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-11001935

This program is all about helping Nigerian biostatisticians gain the skills they need to lead and collaborate on important HIV research, so they can better support their communities and improve health outcomes in West Africa.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorVANDERBILT UNIVERSITY MEDICAL CENTER (nih funded)
Locations1 site (NASHVILLE, UNITED STATES)
Trial IDNIH-11001935 on ClinicalTrials.gov

What this research studies

This program aims to enhance biostatistics expertise in West Africa, specifically focusing on HIV research. It addresses the current gap where biostatistical leadership in collaborative studies is predominantly from the U.S. The initiative will train Nigerian biostatisticians to become co-investigators and leaders in HIV-related research, fostering local capacity and collaboration. By establishing a training platform at Aminu Kano Teaching Hospital and Vanderbilt University, the program seeks to create a skilled cohort of professionals who can effectively contribute to biomedical research.

Who could benefit from this research

Good fit: Ideal candidates for this program are individuals pursuing advanced degrees in biostatistics or related fields in Nigeria who are interested in HIV research.

Not a fit: Patients who are not involved in academic or research settings, or those outside of Nigeria, may not benefit directly from this program.

Why it matters

Potential benefit: If successful, this research could significantly improve the quality and effectiveness of HIV research in West Africa by developing local biostatistical expertise.

How similar studies have performed: Previous training initiatives in Southern and East Africa have successfully built biostatistics capacity, indicating a promising potential for this program in West Africa.

Where this research is happening

NASHVILLE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.